ASC 30
Alternative Names: ASC-30Latest Information Update: 16 Oct 2024
At a glance
- Originator Ascletis
- Class Obesity therapies; Small molecules
- Mechanism of Action Glucagon-like peptide-1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Obesity